Search results
Results from the WOW.Com Content Network
In 2015, the UK had around 225 main biotechnology companies, turning over around £2.9bn. [2] Exports accounted for around £1.5bn of turnover. The UK has an estimated 5% share of the global market. In Europe, by patent applications submitted under the Patent Cooperation Treaty, the UK is third, second to Germany and France but seventh in the ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Zymergen was founded in 2013. [5] by investment banker Joshua Hoffman, biophysicist Zach Serber, and biochemist Jed Dean. [6]All three met while working at Amyris, Inc. [7] The company uses machine learning and artificial intelligence to study and modify microbes which ferment carbon [6] to produce chemicals used in manufacturing consumer goods and pharmaceuticals. [8]
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
In the European region, there are multiple stock exchanges among which five are considered major (as having a market cap of over US$1 trillion): . Euronext, which is a pan-European, Dutch-domiciled and France-headquartered stock exchange composed of seven market places in Belgium, France, Ireland, the Netherlands, Italy, Norway, and Portugal.
The first Ebola vaccine in the world was developed in the IRBM Science Park laboratories, Pomezia, Rome, Italy. [3]In the laboratories of the IRBM Science Park a team of Italian and American researchers has developed the Chad3Ebola-Zaire anti-ebola vaccine, a monovalent adenovirus capable of neutralizing the «Zaire» strain of the virus, conceived and produced by OKAIROS, a biotech company ...
The field of synthetic biology has not been good to investors. But maybe we've just been looking in the wrong places. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 ...
When completed, the facility will be one of the world's largest plants supporting single-use bioreactors and will help accelerate the development of biologic drugs in Europe. [24] MFG6 will have a perfusion bioreactor capacity of 6,000 liters in a continuous bioprocessing configuration and MFG7 will have a 48,000 liter bioreactor capacity in a ...